BRCA2 and pancreatic neoplasm: Signature 3 has been previously reported in breast and pancreatic cancers and shows a strong association with germline and somatic BRCA1 and BRCA2 mutations, leading to defective homologous recombination repair of DNA double-strand breaks (34–36).